Krishana Phoschem Q1 FY27 Earnings Call Transcript Released; Revenue Up 35% YoY
Krishana Phoschem reported Q1 FY27 revenue of ₹532 crore, up 35% YoY, and PAT of ₹47 crore, up 54% YoY. The company expects to achieve a quarterly turnover of over ₹500 crore in the remaining quarters of FY27. They have also introduced new complex fertilizer variants and are confident in maintaining healthy EBITDA margins.
The positive financial results and outlook are significant for the company's performance and investor confidence, but the impact is moderate as it's a routine quarterly update.
The company reported strong year-on-year growth in revenue, EBITDA, and profit after tax, along with positive commentary on future outlook and strategic initiatives.
Krishana Phoschem Limited has released the transcript of its Q1 FY27 Earnings Conference Call, which was held on July 14, 2026. The company reported a resilient performance despite a challenging operating environment marked by global supply-side disruptions, elevated raw material prices, and geopolitical uncertainties.
During the quarter, Krishana Phoschem achieved a revenue of ₹532 crore, representing a 35% year-on-year growth. EBITDA stood at ₹89 crore, up 36% year-on-year, and profit after tax was ₹47 crore, a 54% increase year-on-year. Earnings per share rose to ₹1.52 from ₹0.99 in the same quarter last year. The company produced 89,747 metric tonnes of fertilizer, with capacity utilization at 43% for the NPK-DAP unit and 121% for the SSP unit.
The company highlighted several favorable developments including increased Minimum Support Prices (MSPs) for Kharif crops, continued government support through the Nutrient Based Subsidy (NBS) framework, and a revival in monsoon activity. Krishana Phoschem also recently executed a 5-for-1 stock split to enhance market liquidity and investor affordability.
Strategic business initiatives included the introduction of additional variants of complex fertilizers to meet evolving crop nutrition requirements. Looking ahead, the company expects a steady ramp-up in NPK capacity utilization, driving revenue growth and profitability. They are confident in maintaining healthy EBITDA margins, driven by product mix and operational efficiencies, and anticipate achieving a quarterly turnover of over ₹500 crore in the remaining quarters of FY27.
What to do with a filing like this
Krishana Phoschem Limited filed this with the NSE as a statutory disclosure, categorised under concall transcript released. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Krishana Phoschem Limited. Read the original for the full detail.